Sign in
LEXXW Stock Price, Chart, Stats & News
Lexaria Bioscience Corp.
Save
Lexaria Bioscience Corp. (LEXXW) does not currently pay a dividend.
29,687
Market cap
–
Current P/E
–
Forward P/E
LEXXW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 84.90% |
Operating margin | -2021.04% |
Pretax margin | -2069.06% |
Net margin | -2067.65% |
Effective tax rate | -0.02% |
ROA | -178.38% |
ROE | -209.58% |
D/E | 0.02x |
Interest coverage ratio | – |
LEXXW valuation
P/E | – |
P/S | 27.49x |
P/B | 3.23x |
P/CF | -1.82x |
P/FCF | -1.65x |
P/OCF | -1.82x |
PEG | -0.11x |
EV multiple | -1.73x |
About
Lexaria Bioscience Corp. is a biotechnology firm specializing in the creation and licensing of its patented drug delivery system, DehydraTECH. This innovative technology functions by integrating fat-soluble compounds or active pharmaceutical ingredients (APIs) with particular long-chain fatty acids and specific carrier substances. The aim of this process is to significantly boost their entry into the bloodstream, consequently enhancing their effectiveness, enabling lower overall dosages, and supporting healthier methods of oral consumption.
Similar securities
Based on sector and market capitalization
Report issue